News and Trends 15 Jul 2022 European biotech stock woes continue but recovery hope remains European biotech stocks continue to disappoint, with half of listed biotechs in the region having just 12 months of cash left. However, a recent report from Bryan, Garnier & Co sees a strong biotech venture capital scene and rallying stocks as reasons to be optimistic. Biotech stocks have performed poorly in the last year as […] July 15, 2022 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 28 Jun 2022 Breast cancer drug recommended for approval A cancer drug from AstraZeneca and Daiichi Sankyo called Enhertu, that reduces the risk of disease progression or even death by 72%, has been recommended for approval in the European Union (EU). The drug containing trastuzumab deruxtecan is specifically engineered for patients with human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer treated with […] June 28, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 27 Jun 2022 Covid vaccine granted marketing authorization in Europe Specialty vaccine company, Valneva, has been given marketing authorization in Europe for its inactivated whole-virus COVID-19 vaccine VLA2001. This is a turnaround from the company’s situation in May of this year when the stock price was knocked down by 20% when gaining traction in the EU was proving to be a struggle. Despite authorization from […] June 27, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email